Please save the date for a ribbon cutting of the Brain Tumor Biotech Center at The Feinstein Institute for Medical Research.
The Brain Tumor Biotech Center is an interactive hub for scientists, clinicians and biotech companies in the neuro-oncology space to join forces to accelerate the delivery of novel drugs to patients with brain tumors. The Brain Tumor Biotech Center is lead by John Boockvar, MD, and Marc Symons, PhD.
Guest speakers at this event will include Michael Dowling, CEO of the North Shore-LIJ Health System; Kevin J. Tracey, MD, president of the Feinstein Institute; and Anthony Scaramucci, founder & co-managing partner of SkyBridge Capital.
Valet parking will be provided and refreshments will be served.
The post Brain Tumor Biotech Center Ribbon Cutting appeared first on The Feinstein Institute for Medical Research.